Stock Market & Financial Investment News

News Breaks November 9, 2012 05:58 EDT CPIX Cumberland downgraded to Market Perform from Outperform at Wells Fargo Wells Fargo downgraded Cumberland Pharmaceuticals citing risk to the Acetadote franchise after the FDA approved Innopharma's potential generic. The firm lowered its price target range for shares to $6-$7 from $8-$9. News For CPIX From The Last 14 Days Check below for free stories on CPIX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:34 EDT CPIX UBS to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.